DK0477143T3 - Farmaceutisk præparat med en ardannende virkning - Google Patents

Farmaceutisk præparat med en ardannende virkning

Info

Publication number
DK0477143T3
DK0477143T3 DK91830353.8T DK91830353T DK0477143T3 DK 0477143 T3 DK0477143 T3 DK 0477143T3 DK 91830353 T DK91830353 T DK 91830353T DK 0477143 T3 DK0477143 T3 DK 0477143T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical composition
composition
effect
scarring effect
scarring
Prior art date
Application number
DK91830353.8T
Other languages
English (en)
Inventor
Decimo Guarnieri
Piera Fileccia
Original Assignee
Idi Farmaceutici Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idi Farmaceutici Spa filed Critical Idi Farmaceutici Spa
Application granted granted Critical
Publication of DK0477143T3 publication Critical patent/DK0477143T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/01—Peroxidases (1.11.1)
    • C12Y111/01006—Catalase (1.11.1.6)
DK91830353.8T 1990-08-30 1991-08-21 Farmaceutisk præparat med en ardannende virkning DK0477143T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT48244A IT1241994B (it) 1990-08-30 1990-08-30 Composizione farmaceutica ad effetto cicatrizzante.

Publications (1)

Publication Number Publication Date
DK0477143T3 true DK0477143T3 (da) 1996-07-08

Family

ID=11265451

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91830353.8T DK0477143T3 (da) 1990-08-30 1991-08-21 Farmaceutisk præparat med en ardannende virkning

Country Status (6)

Country Link
EP (1) EP0477143B1 (da)
AT (1) ATE136787T1 (da)
DE (1) DE69118796T2 (da)
DK (1) DK0477143T3 (da)
ES (1) ES2086518T3 (da)
IT (1) IT1241994B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5526499A (en) * 1998-08-28 2000-03-21 University Of Bath, The Ingestible compositions comprising antibacterial agents
FR2809310B1 (fr) 2000-05-26 2004-02-13 Centre Nat Rech Scient Utilisation de derives de biguanide pour fabriquer un medicament ayant un effet cicatrisant

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1118M (fr) * 1961-03-17 1962-02-12 Rech S Ind S O R I Soc D La catalase, son introduction en thérapeutique humaine comme accélérateur de la fibrogenese.
DE1252610B (de) * 1964-01-08 1967-10-26 SINCOREP SA, Fnbourg (Schweiz) Verfahren zum Stabilisieren von Katalase

Also Published As

Publication number Publication date
ATE136787T1 (de) 1996-05-15
EP0477143B1 (en) 1996-04-17
DE69118796T2 (de) 1996-10-24
IT9048244A0 (it) 1990-08-30
DE69118796D1 (de) 1996-05-23
IT9048244A1 (it) 1992-03-01
ES2086518T3 (es) 1996-07-01
EP0477143A2 (en) 1992-03-25
IT1241994B (it) 1994-02-02
EP0477143A3 (en) 1993-02-24

Similar Documents

Publication Publication Date Title
DE69214938T2 (de) Mittel zur topischen verabreichung von arzneiwirkstoffen
EP0142426A3 (en) Ophthalmic formulation containing norfloxacin and related antibiotics
CA2304958A1 (en) Bioadhesive compositions and methods for topical administration of active agents
MXPA02002895A (es) Tratamiento topico de infecciones por estreptococcus.
WO1995030410A3 (en) Transdermal device for administration through de-epithelialized skin
IL153665A0 (en) Topical pharmaceutical formulations and methods of treatment
ZA872120B (en) Pharmaceutical composition
EP0391905A4 (en) Hemorrhoidal, other compositions and methods of treatment
ATE235229T1 (de) Liposomale antibakterielle zusammensetzung mit geringer festigkeit
AU4135289A (en) Pharmaceutically active combination
AU681452B2 (en) Pernasal composition and pernasal preparation containing thesame
CA2136331A1 (en) New pharmaceutical uses of krill enzymes
NZ326061A (en) Otic microbial combinations
AU3459689A (en) Treatment of skin disorders
CA2200480A1 (en) New use of prostaglandins
CA2031817A1 (en) Use of thrombospondin to promote wound healing
WO1999026589A3 (en) Composition for the treatment of burns, sunburns, abrasions, ulcers and cutaneous irritation
AU6889196A (en) Long active composition for rectal administration
ES2095578T3 (es) Composicion para el tratamiento de mastitis y metritis.
DK0477143T3 (da) Farmaceutisk præparat med en ardannende virkning
DE69635806D1 (de) Diphosphonat derivate von therapeutisch wirksamen stoffen
CA2336773A1 (en) Component b as angiogenic agent in combination with human growth factors
RU2003337C1 (ru) Ранозаживл ющее средство
JP2002520292A5 (ja) ヒト成長因子と組み合わせた脈管形成剤としてのコンポーネントｂの使用
CA2097878A1 (en) Therapeutic agent for neutropenia